QINGDAO, China, April 27, 2026 /PRNewswire/ -- Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generation, proprietary Brain-Computer ...

MintNeuro, a pioneer of scalable, low-power semiconductor technology for neural implant applications, and Motif Neurotech, a therapeutic brain-computer interface (BCI) company developing miniature ...

CorTec GmbH today announced that the first participant in the University of Washington’s NIH-funded clinical trial of the Brain Interchange™ BCI system has successfully controlled a computer through ...

CorTec GmbH today announced that the U.S. Food and Drug Administration (FDA) has accepted the company into its Total Product Life Cycle Advisory Program (TAP), recognizing the Brain Interchange™ BCI ...

Akso Health Group (NASDAQ: AHG) ("Akso Health" or the "Company") today announced the commencement of its next-generation, proprietary Brain-Computer Interface (BCI) technology research and development ...

A tiny brain implant, no bigger than a blueberry, is moving from lab concept ...

CU Anschutz and UCHealth are leading the way in advanced care and research for people with neurological diseases and injuries ...

CorTec today announced a major milestone for the first participant in a trial for its Brain Interchange brain-computer ...

Neurable, the leader in AI for noninvasive brain-computer interface (BCI) technology, today announced its official transition ...

The field of brain-computer interfaces is moving away from mind-controlled computer cursors to restoring speech.

Motif Neurotech, a brain-computer interface (BCI) company developing technologies for mental health, today announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational ...

"Our work highlights how combining clinical expertise with real-time data systems and automated digital tools can improve ...